1. Home
  2. PSTV vs AGMH Comparison

PSTV vs AGMH Comparison

Compare PSTV & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • AGMH
  • Stock Information
  • Founded
  • PSTV 1996
  • AGMH 2015
  • Country
  • PSTV United States
  • AGMH Hong Kong
  • Employees
  • PSTV N/A
  • AGMH N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • AGMH EDP Services
  • Sector
  • PSTV Health Care
  • AGMH Technology
  • Exchange
  • PSTV Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • PSTV 2.1M
  • AGMH 1.8M
  • IPO Year
  • PSTV N/A
  • AGMH 2018
  • Fundamental
  • Price
  • PSTV $0.77
  • AGMH $0.05
  • Analyst Decision
  • PSTV Strong Buy
  • AGMH
  • Analyst Count
  • PSTV 3
  • AGMH 0
  • Target Price
  • PSTV $11.17
  • AGMH N/A
  • AVG Volume (30 Days)
  • PSTV 30.3M
  • AGMH 39.0M
  • Earning Date
  • PSTV 03-27-2025
  • AGMH 04-15-2025
  • Dividend Yield
  • PSTV N/A
  • AGMH N/A
  • EPS Growth
  • PSTV N/A
  • AGMH N/A
  • EPS
  • PSTV N/A
  • AGMH N/A
  • Revenue
  • PSTV $5,824,000.00
  • AGMH $64,998,081.00
  • Revenue This Year
  • PSTV N/A
  • AGMH N/A
  • Revenue Next Year
  • PSTV N/A
  • AGMH N/A
  • P/E Ratio
  • PSTV N/A
  • AGMH N/A
  • Revenue Growth
  • PSTV 18.54
  • AGMH N/A
  • 52 Week Low
  • PSTV $0.24
  • AGMH $0.04
  • 52 Week High
  • PSTV $2.67
  • AGMH $2.19
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 43.96
  • AGMH 24.10
  • Support Level
  • PSTV $0.94
  • AGMH $0.04
  • Resistance Level
  • PSTV $1.77
  • AGMH $0.06
  • Average True Range (ATR)
  • PSTV 0.31
  • AGMH 0.01
  • MACD
  • PSTV -0.03
  • AGMH 0.03
  • Stochastic Oscillator
  • PSTV 17.92
  • AGMH 7.14

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: